Asymchem Laboratories (Tianjin) Co., Ltd. (SHE:002821)

Market Cap	33.70B
Revenue (ttm)	6.29B
Net Income (ttm)	1.04B
Shares Out	359.44M
EPS (ttm)	2.86
PE Ratio	33.51
Forward PE	26.44
Dividend	1.10 (1.18%)
Ex-Dividend Date	Jun 26, 2025

Volume	5,838,654
Average Volume	3,205,425
Open	93.20
Previous Close	92.93
Day's Range	92.79 - 96.88
52-Week Range	59.90 - 125.50
Beta	0.18
RSI	45.74
Earnings Date	Mar 31, 2026

About SHE:002821

Asymchem Laboratories (Tianjin) Co., Ltd. provides clinical stage CDMO, commercial stage CDMO, and emerging services in Mainland China and internationally. The company offers API solutions, such as small molecules, highly potent, carbapenems, glycans, peptides, oligonucleotides, and therapeutic enzymes; GMP, non-GMP, asymchem lab facilities and capabilities, commercial manufacturing, clinical manufacturing, separations, crystallization, fermentation, continuous FlowGMP, non-GMP, Asymchem lab facilities and capabilities, commercial manufacturing...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1998
• Employees: 9,595
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002821

Financial Performance

In 2024, SHE:002821's revenue was 5.80 billion, a decrease of -25.82% compared to the previous year's 7.83 billion. Earnings were 948.95 million, a decrease of -58.17%.